Latest News about ulcerative colitis
Recent news which mentions ulcerative colitis
Pfizer's Ulcerative Colitis Candidate Aces Late-Stage Study
March 23, 2022
Tickers
PFE
From Benzinga
Nearly 66% Of Patients Respond To Eli Lilly's Mirikizumab In Ulcerative Colitis Study
February 18, 2022
Tickers
LLY
From Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
January 10, 2022
Tickers
GLMD
From Benzinga
Bristol Myers' Zeposia Wins European Approval For Ulcerative Colitis
November 23, 2021
Tickers
BMY
From Benzinga
Ventyx Jumps Over 20% Today After NASDAQ Debut
October 21, 2021
From Benzinga
Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients
October 05, 2021
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
October 01, 2021
Tickers
LLY
From Benzinga
From Benzinga
Seres Therapeutics Stock Plunges As Ulcerative Colitis Candidate Disappoints In Mid-Stage Study
July 22, 2021
Tickers
MCRB
From Benzinga
Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients
July 15, 2021
From Benzinga
Eli Lilly's Mirikizumab Shows Mucosal Healing In Ulcerative Colitis Maintained For Up To One Year
July 09, 2021
Tickers
LLY
From Benzinga